This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Pharma Stocks Trading for Under $2

Biodel (BIOD) focuses on the development and commercialization of treatments for diabetes. For the fourth quarter ended Sept. 30, the company reported a narrower loss of $8.1 million, or 31 cents a share, from $10.5 million, or 44 cents a share, a year earlier. The loss was narrower than analysts' estimates of a loss of 37 cents. At the end of the quarter, cash, cash equivalents, restricted cash, and marketable securities stood at $29.1 million.

During 2011, the company seeks to conduct pre-clinical studies and Phase I clinical trials to determine whether one or more of its newer insulin formulations is likely to offer a combination of pharmacokinetic stability and tolerability characteristics that are preferable to its current formulation of Linjeta -- a human insulin for Type I and Type II Diabetes.

Of the six analysts covering the stock, one analyst recommends buying it while five recommend holding it. Currently, the stock is trading at $1.69. The target price is $4.50, indicating an upside of 166%.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACAD $17.65 -8.80%
BIOD $0.27 -0.81%
CBRX $6.19 -22.14%
RPRX $0.92 -11.00%
BPAX $55.05 -1.24%


Chart of I:DJI
DOW 15,918.36 -286.61 -1.77%
S&P 500 1,840.69 -39.36 -2.09%
NASDAQ 4,258.8210 -104.3230 -2.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs